Viral Vector

Bringing Excellence in Manufacturing & Quality to the Rapidly Growing Cell and Gene Therapy Market

Investing $75 Million into the future of Cell & Gene Therapy

We are expanding our CDMO service offering into the rapidly growing cell and gene therapy market. 

The company is constructing a world-class, purpose-built 53,000 sq. ft. viral vector development and CGMP manufacturing facility in Costa Mesa, CA.

Facility

World-Class Viral Vector Development and Manufacturing Facility Being Built in Orange County, CA

  • Located in Costa Mesa, California approximately 5 miles from our existing campus
  • State of the Art Process Development and Quality Control Laboratory Space
  • World Class CGMP Manufacturing Space

 

Process Development

  • Experience with Various Vector Types
    • AAV, Lentiviral Vector, Adenoviral Vector
  • Offering a Wide Range of Viral Vector Characterization Assays
  • Develop and/or Tech Transfer:
    • Client-Specific Assays
    • Viral Vector Production
    • Viral Vector Purification
    • Generation of Bulk Drug Substance
  • Optimize and Transfer Processes to CGMP Manufacturing
  • Optimize and Transfer Analytical Assays to Quality Control
  • Site-Wide Support for Client-Related Viral Vector Programs

CGMP Manufacturing

  • CGMP Cell & Viral Banking
  • Bioreactor Capacity
    • A Train
      • Capable of up to 250L suspension culture or multi-layer single use vessels for adherent culture
    • B Train
      • Capable of up to 2,000L suspension culture or large scale adherent fixed bed bioreactors
  • Semi-Automated Fill & Finish Capabilities
  • QA Product Release Testing
Close this popup.
We use cookies to improve your experience on our site. To find out more, read our Privacy Policy.